Hong Kong (HSI) Growth Pharmaceuticals & Biotech Stocks

UPDATED Jul 24, 2024

Discover Hong Kong Pharmaceuticals & Biotech Growth Stocks that are on the HSI. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

101 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

6185

CanSino Biologics
HK$18.18-4.9%-36.3%HK$7.2bHK$27.61PS11.3xE124.6%0%

2315

Biocytogen Pharmaceuticals (Beijing)
HK$7.30-14.6%-63.5%HK$2.9bHK$15.39PS3.8xE100.1%n/a

2616

CStone Pharmaceuticals
HK$1.20-3.2%-50.6%HK$1.5bHK$2.91PS3.1xE98.1%n/a

1548

Genscript Biotech
HK$13.10-0.9%-32.4%HK$27.9bHK$24.14PS4.3xE97.9%0%

1477

Ocumension Therapeutics
HK$6.90-5.2%-31.1%HK$4.8bHK$9.32PS18.1xE93.7%n/a

2487

Cutia Therapeutics
HK$7.707.7%-62.3%HK$2.3bHK$12.47PS15.9xE84.3%n/a

1952

Everest Medicines
HK$18.88-7.0%-15.0%HK$6.1bHK$25.97PS44.8xE76.3%n/a

2228

QuantumPharm
HK$5.814.9%n/aHK$19.8bHK$7.30PS105.7xE69.5%n/a

9966

Alphamab Oncology
HK$2.20-4.8%-76.2%HK$2.1bHK$4.28PS9xE64.2%n/a

9995

RemeGen
HK$14.20-16.1%-67.1%HK$12.5bHK$37.79PS5.7xE54.1%n/a

1801

Innovent Biologics
HK$40.25-2.2%18.6%HK$65.5bHK$55.81PS9.8xE50.5%n/a

2268

WuXi XDC Cayman
HK$14.24-5.3%n/aHK$17.1bHK$30.65PE56xE44.6%n/a

2480

Beijing Luzhu Biotechnology
HK$23.80-2.7%-26.3%HK$4.8bHK$29.98PB4.4xE36.3%n/a

1521

Frontage Holdings
HK$0.74-6.3%-69.3%HK$1.5bHK$1.54PE17.7xE34.9%n/a

2179

Jiangsu Recbio Technology
HK$8.980.1%-25.7%HK$4.3bHK$12.99PS132xE32.6%n/a

6990

Sichuan Kelun-Biotech Biopharmaceutical
HK$150.70-3.1%95.2%HK$33.6bHK$201.19PS20.3xE31.2%n/a

2137

Brii Biosciences
HK$1.01-9.8%-69.7%HK$737.1mHK$6.00PS12.2xE29.5%n/a

9939

Kintor Pharmaceutical
HK$1.02-2.9%-73.8%HK$448.2mHK$14.14PB0.9xE27.0%n/a

2186

Luye Pharma Group
HK$2.78-3.1%-23.8%HK$10.5bHK$3.05PE18.3xE26.8%0%

9969

InnoCare Pharma
HK$4.50-10.0%-41.3%HK$9.3bHK$8.84PS10.3xE26.4%n/a

2096

Simcere Pharmaceutical Group
HK$5.39-4.9%-29.7%HK$13.6bHK$8.59PE17.8xE23.8%3.2%

1877

Shanghai Junshi Biosciences
HK$11.62-8.1%-53.4%HK$27.0bHK$14.39PS6.5xE23.7%n/a

2126

JW (Cayman) Therapeutics
HK$1.76-4.9%-36.5%HK$711.5mHK$2.97PS3.8xE20.6%n/a

2171

CARsgen Therapeutics Holdings
HK$4.36-2.9%-59.0%HK$2.5bHK$7.20PB1.3xE20.4%n/a
Page 1 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.